Indoleamine 2,3 dioxygenase as a prognostic and follow‐up marker in melanoma. A comparative study with LDH and S100B
Lecea, M.V., Palomares, T., Al Kassam, D., Cavia, M., Geh, J.L.C., de Llano, P., Muñiz, P., Armesto, D., Martinez‐Indart, L., Alonso‐Varona, A.
Published in Journal of the European Academy of Dermatology and Venereology (01.04.2017)
Published in Journal of the European Academy of Dermatology and Venereology (01.04.2017)
Get full text
Journal Article